Science

Bibi Maryam: The prognostic role of ctDNA clearance in localized and metastatic RCC

Bibi Maryam/X

Feb 12, 2025, 15:01

Bibi Maryam: The prognostic role of ctDNA clearance in localized and metastatic RCC

Bibi Maryam, Resident Physician at University of Oklahoma, shared an article by Adanma Ayanambakkam, et al. on X:

“Excited to share our abstract on the prognostic role of circulating tumor DNA (ctDNA) clearance as a biomarker in localized and metastatic renal cell carcinoma for ⁦ASCO GU25.

Grateful to work with⁦⁦ Adanma Ayanambakkam⁩ on this.”

The prognostic role of circulating tumor DNA (ctDNA) clearance as a biomarker in localized and metastatic renal cell carcinoma (RCC): A single-center experience.

Authors: Adanma Ayanambakkam, et al.

Bibi Maryam: The prognostic role of ctDNA clearance in localized and metastatic RCC

Adanma Ayanambakkam ASCO Bibi Maryam cancer Circulating tumor DNA ctDNA fight against cancer Global fight against cancer GU25 OncoDaily Oncology RCC renal cell carcinoma University of Oklahoma

ACT for Children: Tackling Inequities in Childhood Cancer Through Unique Global Collaboration

Richard Gere and Alejandra Gere to Join Second Global OncoThon on February 15 for Fight Against Childhood Cancer

Mesothelioma Guideline Updates from ASCO 2024: Key Advances in Diagnosis and Treatment

Oncologist Near Me - Lynn Schuchter: A Pioneering Leader in Cancer Care and Melanoma Research

NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%